세계의 조직학 및 세포학 시장 : 시장 규모 조사 - 시험 유형별, 제품별, 검사 유형별, 용도별, 최종 사용자별, 지역별 예측(2022-2032년)

Global Histology and Cytology Market is valued approximately at USD 8.06 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 11.9% over the forecast period 2024-2032. Histology is the study of the microscopic structure of tissues. This field involves examining tissues under a microscope to understand their architecture, composition, and function. Histologists use a variety of staining techniques to differentiate between different types of cells and tissues, making it easier to observe their characteristics and identify any abnormalities. Histology is crucial in diagnosing diseases, understanding the complex structure of organs, and studying how tissues function and respond to various conditions. Cytology is the study of individual cells, focusing on their formation, structure, and function. This discipline is often used in medical diagnostics to detect and study diseases at the cellular level, particularly cancer. Cytologists examine samples of cells from body fluids, tissues, or scrapings under a microscope to look for abnormalities such as changes in cell size, shape, or organization. Cytology is widely used in screening tests like the Pap smear, which helps detect cervical cancer in its early stages.

The rising prevalence of chronic diseases, such as cancer, is a significant driver for the histology market. Histology and cytology techniques are crucial in the diagnosis and monitoring of various diseases. For instance, according to an article published in the National Library of Medicine in 2022, 1,918,030 new cancer cases and 609,360 cancer deaths are projected to occur in the United States, including approximately 350 deaths per day from lung cancer, the leading cause of cancer death. In addition, ongoing technological advancements in histology and cytology techniques, including automation, digital pathology, and molecular pathology, contribute to the growth of the market. Additionally, the aging demographic is frequently linked to a higher prevalence of illnesses necessitating histological and cytological scrutiny. With the aging of the world's population, there's an anticipated surge in demand for diagnostic services. Furthermore, the increased recognition of the significance of early disease identification, combined with the introduction of screening initiatives, amplifies this demand, propelling growth in the histology and cytology market. However, high cost of treatment and lack of trained professionals would hamper the market growth during the forecast period 2024-2032.

The key regions considered for the Global Histology And Cytology Market study include Asia Pacific, North America, Europe, Latin America, and Middle East and Africa. North America accounted for the largest histology and cytology market share in terms of revenue in 2023, owing to the increasing prevalence of chronic diseases, such as cancer. Advances in medical technology and imaging techniques have also propelled the market forward, enhancing the accuracy and efficiency of histological and cytological examinations. Moreover, Asia-Pacific is projected to exhibit the fastest CAGR in the histology market during the forecast period. This growth is attributed to rise in awareness about the importance of early disease detection and preventive healthcare measures. Furthermore, advancements in healthcare infrastructure, increases in healthcare expenditure, and rise in accessibility to diagnostic services in urban and rural areas contribute to the expanding market. The region's aging population has led to a surge in age-related diseases, necessitating more histopathological and cytological analyses.

Major market players included in this report are:

• Becton, Dickinson, and Company
• F. Hoffmann-La Roche Ltd.
• Hologic, Inc.
• Abbott Laboratories
• Danaher Corporation
• Merck KGaA
• Koninklijke Philips N.V.
• Trivitron Healthcare Private Limited
• Thermo Fisher Scientific, Inc.
• Sysmex Corporation
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Cell Signaling Technology, Inc.
• DiaSorin S.p.A.
• Illumina, Inc.

The detailed segments and sub-segment of the market are explained below:

By Type of Examination:

• Histology
• Cytology

By Product:

• Instruments and Analysis Software System
• Consumable and Reagents

By Test Type:

• Microscopy Methods
• Flow Cytometry
• Molecular Genetic Methods

By Application:

• Drug Discovery and Designing
• Clinical Diagnostics
• Academic Research

By End User:

• Pharma and Biotech Companies
• CDMO
• Diagnostic Laboratories
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia-Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East and Africa
• Saudi Arabia
• South Africa
• Rest of Middle East and Africa

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Histology and Cytology Market Executive Summary

• 1.1. Global Histology and Cytology Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Type of Examination
  • 1.3.2. By Product
  • 1.3.3. By Test Type
  • 1.3.4. By Application
  • 1.3.5. By End User
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Histology and Cytology Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Histology and Cytology Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Rising prevalence of chronic diseases
  • 3.1.2. Technological advancements
  • 3.1.3. Aging population
• 3.2. Market Challenges
  • 3.2.1. High cost of treatment
  • 3.2.2. Lack of trained professionals
• 3.3. Market Opportunities
  • 3.3.1. Expansion of diagnostic services
  • 3.3.2. Adoption of precision medicine
  • 3.3.3. Technological innovations

Chapter 4. Global Histology and Cytology Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Histology and Cytology Market Size & Forecasts by Type of Examination 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Histology and Cytology Market: Type of Examination Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.2.1. Histology
  • 5.2.2. Cytology

Chapter 6. Global Histology and Cytology Market Size & Forecasts by Product 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Histology and Cytology Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.2.1. Instruments and Analysis Software System
  • 6.2.2. Consumable and Reagents

Chapter 7. Global Histology and Cytology Market Size & Forecasts by Test Type 2022-2032

• 7.1. Segment Dashboard
• 7.2. Global Histology and Cytology Market: Test Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 7.2.1. Microscopy Methods
  • 7.2.2. Flow Cytometry
  • 7.2.3. Molecular Genetic Methods

Chapter 8. Global Histology and Cytology Market Size & Forecasts by Application 2022-2032

• 8.1. Segment Dashboard
• 8.2. Global Histology and Cytology Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 8.2.1. Drug Discovery and Designing
  • 8.2.2. Clinical Diagnostics
  • 8.2.3. Academic Research

Chapter 9. Global Histology and Cytology Market Size & Forecasts by End User 2022-2032

• 9.1. Segment Dashboard
• 9.2. Global Histology and Cytology Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 9.2.1. Pharma and Biotech Companies
  • 9.2.2. CDMO
  • 9.2.3. Diagnostic Laboratories
  • 9.2.4. Others

Chapter 10. Global Histology and Cytology Market Size & Forecasts by Region 2022-2032

• 10.1. North America Histology and Cytology Market
  • 10.1.1. U.S. Histology and Cytology Market
    • 10.1.1.1. Type of Examination breakdown size & forecasts, 2022-2032
    • 10.1.1.2. Product breakdown size & forecasts, 2022-2032
    • 10.1.1.3. Test Type breakdown size & forecasts, 2022-2032
    • 10.1.1.4. Application breakdown size & forecasts, 2022-2032
    • 10.1.1.5. End User breakdown size & forecasts, 2022-2032
  • 10.1.2. Canada Histology and Cytology Market
• 10.2. Europe Histology and Cytology Market
  • 10.2.1. Germany Histology and Cytology Market
  • 10.2.2. France Histology and Cytology Market
  • 10.2.3. UK Histology and Cytology Market
  • 10.2.4. Italy Histology and Cytology Market
  • 10.2.5. Spain Histology and Cytology Market
  • 10.2.6. Rest of Europe Histology and Cytology Market
• 10.3. Asia-Pacific Histology and Cytology Market
  • 10.3.1. China Histology and Cytology Market
  • 10.3.2. India Histology and Cytology Market
  • 10.3.3. Japan Histology and Cytology Market
  • 10.3.4. Australia Histology and Cytology Market
  • 10.3.5. South Korea Histology and Cytology Market
  • 10.3.6. Rest of Asia Pacific Histology and Cytology Market
• 10.4. Latin America Histology and Cytology Market
  • 10.4.1. Brazil Histology and Cytology Market
  • 10.4.2. Mexico Histology and Cytology Market
  • 10.4.3. Rest of Latin America Histology and Cytology Market
• 10.5. Middle East & Africa Histology and Cytology Market
  • 10.5.1. South Africa Histology and Cytology Market
  • 10.5.2. North Africa Histology and Cytology Market
  • 10.5.3. Rest of MEA Histology and Cytology Market

Chapter 11. Competitive Intelligence

• 11.1. Key Company SWOT Analysis
• 11.2. Top Market Strategies
• 11.3. Company Profiles
  • 11.3.1. Becton, Dickinson, and Company
    • 11.3.1.1. Key Information
    • 11.3.1.2. Overview
    • 11.3.1.3. Financial (Subject to Data Availability)
    • 11.3.1.4. Product Summary
    • 11.3.1.5. Market Strategies
  • 11.3.2. F. Hoffmann-La Roche Ltd.
  • 11.3.3. Hologic, Inc.
  • 11.3.4. Abbott Laboratories
  • 11.3.5. Danaher Corporation
  • 11.3.6. Merck KGaA
  • 11.3.7. Koninklijke Philips N.V.
  • 11.3.8. Trivitron Healthcare Private Limited
  • 11.3.9. Thermo Fisher Scientific, Inc.
  • 11.3.10. Sysmex Corporation
  • 11.3.11. Agilent Technologies, Inc.
  • 11.3.12. Bio-Rad Laboratories, Inc.
  • 11.3.13. Cell Signaling Technology, Inc.
  • 11.3.14. DiaSorin S.p.A.
  • 11.3.15. Illumina, Inc.

Chapter 12. Research Process

• 12.1. Research Process
  • 12.1.1. Data Mining
  • 12.1.2. Analysis
  • 12.1.3. Market Estimation
  • 12.1.4. Validation
  • 12.1.5. Publishing
• 12.2. Research Attributes